Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
VP, Chief Accounting Officer
-
Stock Symbol
-
MRSN on Nasdaq
Ashish Mandelia - trading volume in the past year for Mersana Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Restricted Stock Unit |
16.7K |
$45.2K |
$2.71 |
Jan 15, 2024 |
Direct |
Common Stock |
|
| Common Stock |
57.5K |
$33.4K |
$0.58 |
Jan 16, 2025 |
Direct |
|
|
| Restricted Stock Unit |
16.7K |
$9.67K |
$0.58 |
Jan 15, 2025 |
Direct |
Common Stock |
|
| Stock Option (Right to Buy) |
75K |
|
|
Jan 15, 2025 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.